Asangani Lab Posts

Irfan Asangani received an NIH R01 grant for research on the Role of MED1 in the AR-dependent transcription in advanced prostate cancer. Congratulations!

Irfan Asanagi received an award from the Sarcoma Foundation of America for the proposal “EWS-FLI1 triggered opportunistic de novo enhancer assembly activates potential cellular therapy targets in Ewing Sarcoma.” Congratulations!

Congratulations to the Wellen, Asangani, and Marmorstein labs for being awarded an AFCRI Discovery Pilot Grant for a collaborative project called “Probing the metabolism-epigenetics link as a therapeutic target in…

September 3, 2019

A recent paper from the Asangani lab published in Cancer Discovery was highlighted in Penn Medicine News. Congratulations to all the authors!